New drug approval should force the DEA to rethink cannabis-derived medicines
The Food and Drug Adminstration’s approval of Epidiolex, a medication derived from cannabis, could be life-changing for Americans suffering from certain types of epilepsy. It may also have far-reaching implications for U.S. marijuana policy.
No comments:
Post a Comment